Lista de obras - Jackeline Agorreta - Dominio Público Uruguay

5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging

scientific article published on 24 November 2018

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis.

artículo científico publicado en 2017

A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients

artículo científico publicado en 2018

Adrenomedullin expression in a rat model of acute lung injury induced by hypoxia and LPS.

artículo científico publicado en 2004

Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.

artículo científico publicado en 2018

Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

artículo científico publicado en 2015

Complement C4d-specific antibodies for the diagnosis of lung cancer.

artículo científico publicado en 2017

Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype

artículo científico publicado en 2014

Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer

artículo científico publicado en 2010

Effects of acute hypoxia and lipopolysaccharide on nitric oxide synthase-2 expression in acute lung injury.

artículo científico publicado en 2003

Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients

artículo científico publicado en 2015

Identification of importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens

artículo científico publicado en 2008

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

artículo científico publicado en 2017

Individual nodule tracking in micro-CT images of a longitudinal lung cancer mouse model.

artículo científico publicado en 2013

Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis.

artículo científico publicado en 2012

Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance

artículo científico publicado en 2011

Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer. ⬇️

artículo científico publicado en 2013

Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC.

artículo científico publicado en 2012

Prognostic signature of early lung adenocarcinoma based on the expression of ribonucleic acid metabolism-related genes

artículo científico publicado en 2015

RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner

artículo científico publicado en 2013

Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma

artículo científico publicado en 2012

Silica-induced Chronic Inflammation Promotes Lung Carcinogenesis in the Context of an Immunosuppressive Microenvironment ⬇️

artículo científico publicado el 1 de agosto de 2013

Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies.

artículo científico publicado en 2016

TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients

artículo científico publicado en 2014

TGFBI expression is associated with a better response to chemotherapy in NSCLC.

artículo científico publicado en 2010

TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC.

artículo científico publicado en 2014

The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression.

artículo científico publicado en 2010

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma.

artículo científico publicado en 2018

Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases

artículo científico publicado en 2010

VEGF₁₂₁b and VEGF₁₆₅b are weakly angiogenic isoforms of VEGF-A.

artículo científico publicado en 2010

Lista de obras de Jackeline Agorreta

5 protein-based signature for resectable lung squamous cell carcinoma improves the prognostic performance of the TNM staging

A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis.

A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients

Adrenomedullin expression in a rat model of acute lung injury induced by hypoxia and LPS.

Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated Effects.

Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

Complement C4d-specific antibodies for the diagnosis of lung cancer.

Contrasting responses of non-small cell lung cancer to antiangiogenic therapies depend on histological subtype

Development of a novel splice array platform and its application in the identification of alternative splice variants in lung cancer

Effects of acute hypoxia and lipopolysaccharide on nitric oxide synthase-2 expression in acute lung injury.

Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients

Identification of importin 8 (IPO8) as the most accurate reference gene for the clinicopathological analysis of lung specimens

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

Individual nodule tracking in micro-CT images of a longitudinal lung cancer mouse model.

Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis.

Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance

Investigation of complement activation product c4d as a diagnostic and prognostic biomarker for lung cancer. ⬇️

Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC.

Prognostic signature of early lung adenocarcinoma based on the expression of ribonucleic acid metabolism-related genes

RHOB influences lung adenocarcinoma metastasis and resistance in a host-sensitive manner

Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma

Silica-induced Chronic Inflammation Promotes Lung Carcinogenesis in the Context of an Immunosuppressive Microenvironment ⬇️

Successful Immunotherapy against a Transplantable Mouse Squamous Lung Carcinoma with Anti-PD-1 and Anti-CD137 Monoclonal Antibodies.

TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients

TGFBI expression is associated with a better response to chemotherapy in NSCLC.

TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC.

The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression.

The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma.

Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases

VEGF₁₂₁b and VEGF₁₆₅b are weakly angiogenic isoforms of VEGF-A.